York Space Systems to Release Financial Results and Host Conference Call
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy YSS?
Source: Newsfilter
- Earnings Release Schedule: York Space Systems will release its financial results for the quarter and full year ended December 31, 2025, after market close on March 19, 2026, emphasizing the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on the same day at 3:00 PM Mountain Time (5:00 PM Eastern Time) to review financial results and discuss future outlook, reflecting a proactive approach to future developments.
- Webcast Access: Investors can access the conference call live via an audio webcast, enhancing engagement with stakeholders and showcasing the company's modernization efforts in information dissemination.
- Company Overview: York Space Systems is a leading U.S.-based national defense and commercial prime, providing a comprehensive suite of mission-critical solutions, focusing on complex mission requirements, which underscores its significant role in the space ecosystem.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy YSS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on YSS
Wall Street analysts forecast YSS stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 21.650
Low
Averages
High
Current: 21.650
Low
Averages
High
About YSS
York Space Systems Inc., formerly Yellowstone Midco Holdings II, LLC, is a space and defense prime providing a comprehensive suite of mission-critical solutions for national security, government and commercial customers. The Company is a provider to the United States Department of Defense’s (DoD) Proliferated Warfighter Space Architecture (PWSA). The Company has demonstrated Link-16 connectivity from space. It offers mission solutions across several complementary product categories: Components, Subsystems, Spacecraft Platforms, Ground Operation, Global Downlink, and Software-Enabled Services. Its S-CLASS, LX-CLASS, and M-CLASS platforms are versatile spacecraft designed to scale across diverse mission needs. Its proprietary software suites, both in orbit on the spacecraft and on the ground in its operation centers, integrates mission planning, ground operations, and autonomous flight control to deliver low-touch operations across single satellites and large constellations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
York Space Systems to Release Financial Results and Host Conference Call
- Earnings Release Schedule: York Space Systems will release its financial results for the quarter and full year ended December 31, 2025, after market close on March 19, 2026, emphasizing the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on the same day at 3:00 PM Mountain Time (5:00 PM Eastern Time) to review financial results and discuss future outlook, reflecting a proactive approach to future developments.
- Webcast Access: Investors can access the conference call live via an audio webcast, enhancing engagement with stakeholders and showcasing the company's modernization efforts in information dissemination.
- Company Overview: York Space Systems is a leading U.S.-based national defense and commercial prime, providing a comprehensive suite of mission-critical solutions, focusing on complex mission requirements, which underscores its significant role in the space ecosystem.
See More
BETA Technologies Reports Disappointing Q4 Results
- Earnings Miss: BETA Technologies reported a Q4 loss of $2.02 per share, significantly worse than the analyst consensus estimate of a loss of $0.84, indicating substantial challenges in profitability that could undermine investor confidence.
- Sales Beat: Despite the significant losses, the company achieved quarterly sales of $11.133 million, surpassing the analyst consensus of $7.859 million, suggesting some resilience in market demand that could lay the groundwork for future growth.
- Stock Reaction: In pre-market trading, BETA's shares fell 3.1% to $18.67, reflecting a negative investor response to the earnings report, which may lead to increased liquidity pressure in the short term.
- Market Sentiment: The overall market sentiment is bearish, with Dow futures down over 1%, indicating investor concerns about the economic outlook, which could further impact BETA Technologies and other related stocks.
See More
Lisata Therapeutics to be Taken Private by Kuva Labs
- Acquisition Agreement: Lisata Therapeutics Inc has agreed to be taken private by Kuva Labs, offering shareholders $5.00 per share along with a $1.00 contingent value right per share, indicating recognition of the company's future potential.
- Significant Stock Surge: Following the acquisition announcement, Lisata Therapeutics' shares rose 20.3% in pre-market trading to $5.03, reflecting positive market reaction and increased investor confidence in the deal.
- Impact of Privatization: The acquisition will result in Lisata Therapeutics delisting from public markets, potentially providing the company with greater flexibility to focus on long-term strategic goals while mitigating the impact of market volatility on its operations.
- Market Dynamics Shift: The announcement of this deal has sparked interest in other related stocks, demonstrating investor enthusiasm for M&A activity in the biotech sector, which may influence future investment decisions and market trends.
See More
Analysts Recommend Buying Bob’s Discount Furniture
- Company Performance: Bob’s Discount Furniture is experiencing significant growth, driven by consumer demand for affordable options amid rising inflation.
- Market Trends: The current economic climate has led many Americans to seek bargains, positively impacting the company's stock performance.
See More
Wall Street Recommends Investing in This New Space Stock
- Commercial Space Business Growth: The commercial space industry is experiencing significant growth, attracting attention from investors.
- Investor Opportunities: There are new investment avenues in the space sector that are gaining favor on Wall Street.
See More
Wall Street Gives Positive Ratings to York Space Systems
- Analyst Optimism: Major investment banks initiated coverage on York Space Systems (YSS), with six out of nine firms issuing Buy or Outperform ratings, reflecting broad optimism about its positioning in the rapidly expanding aerospace and satellite sector.
- Diverse Price Targets: Analyst price targets range from $29 to $55, with Raymond James setting the highest target at $55, indicating varying perspectives on York's future growth potential and execution risks.
- Stock Price Increase: As of 11:21 a.m. ET on Monday, York's shares rose 1.4% to $26.28, demonstrating a positive market reaction to the analyst ratings, which may drive further investment interest.
- Cautious Ratings Exist: Despite the overall optimism, Truist and Goldman Sachs issued Hold and Neutral ratings with targets of $30 and $29, respectively, suggesting some divergence in market views regarding York's valuation and execution risks.
See More
York Space Systems to Release Financial Results and Host Conference Call
- Earnings Release Schedule: York Space Systems will release its financial results for the quarter and full year ended December 31, 2025, after market close on March 19, 2026, emphasizing the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on the same day at 3:00 PM Mountain Time (5:00 PM Eastern Time) to review financial results and discuss future outlook, reflecting a proactive approach to future developments.
- Webcast Access: Investors can access the conference call live via an audio webcast, enhancing engagement with stakeholders and showcasing the company's modernization efforts in information dissemination.
- Company Overview: York Space Systems is a leading U.S.-based national defense and commercial prime, providing a comprehensive suite of mission-critical solutions, focusing on complex mission requirements, which underscores its significant role in the space ecosystem.
See More
BETA Technologies Reports Disappointing Q4 Results
- Earnings Miss: BETA Technologies reported a Q4 loss of $2.02 per share, significantly worse than the analyst consensus estimate of a loss of $0.84, indicating substantial challenges in profitability that could undermine investor confidence.
- Sales Beat: Despite the significant losses, the company achieved quarterly sales of $11.133 million, surpassing the analyst consensus of $7.859 million, suggesting some resilience in market demand that could lay the groundwork for future growth.
- Stock Reaction: In pre-market trading, BETA's shares fell 3.1% to $18.67, reflecting a negative investor response to the earnings report, which may lead to increased liquidity pressure in the short term.
- Market Sentiment: The overall market sentiment is bearish, with Dow futures down over 1%, indicating investor concerns about the economic outlook, which could further impact BETA Technologies and other related stocks.
See More
Lisata Therapeutics to be Taken Private by Kuva Labs
- Acquisition Agreement: Lisata Therapeutics Inc has agreed to be taken private by Kuva Labs, offering shareholders $5.00 per share along with a $1.00 contingent value right per share, indicating recognition of the company's future potential.
- Significant Stock Surge: Following the acquisition announcement, Lisata Therapeutics' shares rose 20.3% in pre-market trading to $5.03, reflecting positive market reaction and increased investor confidence in the deal.
- Impact of Privatization: The acquisition will result in Lisata Therapeutics delisting from public markets, potentially providing the company with greater flexibility to focus on long-term strategic goals while mitigating the impact of market volatility on its operations.
- Market Dynamics Shift: The announcement of this deal has sparked interest in other related stocks, demonstrating investor enthusiasm for M&A activity in the biotech sector, which may influence future investment decisions and market trends.
See More
Analysts Recommend Buying Bob’s Discount Furniture
- Company Performance: Bob’s Discount Furniture is experiencing significant growth, driven by consumer demand for affordable options amid rising inflation.
- Market Trends: The current economic climate has led many Americans to seek bargains, positively impacting the company's stock performance.
See More
Wall Street Recommends Investing in This New Space Stock
- Commercial Space Business Growth: The commercial space industry is experiencing significant growth, attracting attention from investors.
- Investor Opportunities: There are new investment avenues in the space sector that are gaining favor on Wall Street.
See More
Wall Street Gives Positive Ratings to York Space Systems
- Analyst Optimism: Major investment banks initiated coverage on York Space Systems (YSS), with six out of nine firms issuing Buy or Outperform ratings, reflecting broad optimism about its positioning in the rapidly expanding aerospace and satellite sector.
- Diverse Price Targets: Analyst price targets range from $29 to $55, with Raymond James setting the highest target at $55, indicating varying perspectives on York's future growth potential and execution risks.
- Stock Price Increase: As of 11:21 a.m. ET on Monday, York's shares rose 1.4% to $26.28, demonstrating a positive market reaction to the analyst ratings, which may drive further investment interest.
- Cautious Ratings Exist: Despite the overall optimism, Truist and Goldman Sachs issued Hold and Neutral ratings with targets of $30 and $29, respectively, suggesting some divergence in market views regarding York's valuation and execution risks.
See More
